ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
128.218,59
2,70%
S&P 500
6.114,63
-0,01%
US Dollar vs BRL
5,7048
-0,02%
Bitcoin
97.590,25
0,07%
Brent Oil
74,39
0,00%
As Melhores Corretoras Online
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. MeiraGTx Holdings PLC (MGTX)

  7. MeiraGTx Holdings PLC (MGTX) Notícias

MGTX

MeiraGTx (MGTX)

MeiraGTx Holdings PLC
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:MGTX
DataHoraFonteTítuloCódigoCompanhia
22/01/202510:30GlobeNewswire Inc.MeiraGTx Receives Rare Pediatric Disease Designation from FDA for AAV8-RK-RetGC for the Treatment of Patients with Leber Congenital Amaurosis due to GUCY2D MutationsNASDAQ:MGTXMeiraGTx Holdings PLC
21/01/202523:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGTXMeiraGTx Holdings PLC
21/01/202522:58Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MGTXMeiraGTx Holdings PLC
09/12/202411:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGTXMeiraGTx Holdings PLC
09/12/202410:00GlobeNewswire Inc.MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AAV2-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced XerostomiaNASDAQ:MGTXMeiraGTx Holdings PLC
24/11/202421:27PR Newswire (US)Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive DirectorsNASDAQ:MGTXMeiraGTx Holdings PLC
13/11/202410:34Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MGTXMeiraGTx Holdings PLC
13/11/202410:00GlobeNewswire Inc.MeiraGTx Announces Third Quarter 2024 Financial and Operational Results and Recent Business UpdatesNASDAQ:MGTXMeiraGTx Holdings PLC
22/10/202409:00GlobeNewswire Inc.MeiraGTx Announces Five Posters at the European Society of Gene and Cell Therapy (ESGCT) 2024 Annual CongressNASDAQ:MGTXMeiraGTx Holdings PLC
15/10/202408:00GlobeNewswire Inc.MeiraGTx Announces Positive Data from Randomized, Sham-controlled Clinical Bridging Study of AAV-GAD for the Treatment of Parkinson’s DiseaseNASDAQ:MGTXMeiraGTx Holdings PLC
09/10/202417:30GlobeNewswire Inc.MeiraGTx Announces Poster Presentation on a Potential Treatment for MC4R Genetic Deficiency at the 2024 Society for Neuroscience ConferenceNASDAQ:MGTXMeiraGTx Holdings PLC
12/08/202418:18Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:MGTXMeiraGTx Holdings PLC
12/08/202408:05GlobeNewswire Inc.MeiraGTx Announces $50 Million Offering of Ordinary Shares led by Sanofi and Reports Second Quarter 2024 Financial and Operational ResultsNASDAQ:MGTXMeiraGTx Holdings PLC
12/08/202408:03GlobeNewswire Inc.MeiraGTx Announces Pricing of Offering of Ordinary Shares Led by SanofiNASDAQ:MGTXMeiraGTx Holdings PLC
09/05/202409:00GlobeNewswire Inc.MeiraGTx Reports First Quarter 2024 Financial and Operational ResultsNASDAQ:MGTXMeiraGTx Holdings PLC
24/04/202417:30GlobeNewswire Inc.MeiraGTx to Participate in Upcoming Investor ConferencesNASDAQ:MGTXMeiraGTx Holdings PLC
18/04/202417:30GlobeNewswire Inc.MeiraGTx Announces Oral Presentation at the 2024 American Academy of Oral Medicine (AAOM) Annual ConferenceNASDAQ:MGTXMeiraGTx Holdings PLC
14/03/202409:30GlobeNewswire Inc.MeiraGTx Reports Fourth Quarter and Full Year 2023 Financial and Operational Results and Recent Business UpdatesNASDAQ:MGTXMeiraGTx Holdings PLC
13/02/202410:00GlobeNewswire Inc.MeiraGTx Announces $50 Million Milestone from Janssen PharmaceuticalsNASDAQ:MGTXMeiraGTx Holdings PLC
09/02/202412:10Edgar (US Regulatory)Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:MGTXMeiraGTx Holdings PLC
18/01/202419:17Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:MGTXMeiraGTx Holdings PLC
02/01/202402:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MGTXMeiraGTx Holdings PLC
21/12/202310:30Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:MGTXMeiraGTx Holdings PLC
21/12/202309:00GlobeNewswire Inc.MeiraGTx Announces Asset Purchase Agreement Involving its AAV-RPGR Collaboration for up to $415 millionNASDAQ:MGTXMeiraGTx Holdings PLC
14/11/202310:00GlobeNewswire Inc.MeiraGTx Announces Third Quarter 2023 Financial and Operational ResultsNASDAQ:MGTXMeiraGTx Holdings PLC
30/10/202309:14Dow Jones NewsMeiraGTx Gets $30 Million Investment From SanofiNASDAQ:MGTXMeiraGTx Holdings PLC
30/10/202308:30GlobeNewswire Inc.MeiraGTx Announces $30 Million Strategic Investment from Sanofi; Company Pursuing Multiple Additional Strategic OpportunitiesNASDAQ:MGTXMeiraGTx Holdings PLC
24/10/202309:30GlobeNewswire Inc.MeiraGTx Announces an Oral Presentation and Eight Posters at the European Society of Gene and Cell Therapy (ESGCT) 2023 Annual CongressNASDAQ:MGTXMeiraGTx Holdings PLC
10/08/202309:00GlobeNewswire Inc.MeiraGTx Reports Second Quarter 2023 Financial and Operational ResultsNASDAQ:MGTXMeiraGTx Holdings PLC
01/08/202310:10GlobeNewswire Inc.MeiraGTx Announces Poster Presentation at the 2023 American Society of Gene and Cell Therapy (ASGCT) Spotlight on Immuno-OncologyNASDAQ:MGTXMeiraGTx Holdings PLC
 Apresentando as notícias mais relevantes sobre:NASDAQ:MGTX

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
RNEW4
RENOVA PN
BOV
AZEV4
AZEVEDO PN
BOV
PRIO3
PETRORIO ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
AZEV3
AZEVEDO ON
BOV
FICT3
Fictor Alimentos ON
BOV
AMER3
Americanas ON
BOV
RAIZ4
Raizen S.A PN
BOV
BRSR6
BANRISUL PNB
BOV
RCSL4
RECRUSUL PN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados

Vá sem anúncios

Assine uma experiência sem anúncios

Sem anúncios

Experimente agora

Manter os anúncios